Special Issue Introduction
Special issue webinar: Liver Tumors of Unidentified Primary: are All HCC or HCC-CCA?
Participants1. Yao Luo
Oncology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China.2. Luis Alberto Martinez Insfran
Department of Surgery, Hospital Universitario San Juan de Alicante, Alicante, Spain.3. Federica Pedica
Department of Experimental Oncology, Pathology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.4. Sarah El-Nakeep
Gastroenterology and Hepatology Unit, Internal Medicine Department , Faculty of Medicine, Ain Shams University, Cairo, Egypt.5. Luca Aldrighetti
Hepatobiliary and General Surgery Division, San Raffaele Hospital, Milan, Italy.6. Valli De Re
Immunopathology and Cancer Biomarkers/Bioproteomic facility, Department of Translational Research, Centro di Riferimento Oncologico (CRO) IRCCS, Cancer Institute, Aviano, Italy.7. Anna Rossetto
Department of General Surgery and Transplantation, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.8. Amir A Rahnemai-Azar
Division of Surgical Oncology, Department of Surgery, Arrowhead Regional Cancer Center, California University of Science and Medicine, Colton, CA, USA.